Streetbeat News

Products Services

FIVN

SESTEK has partnered with Five9 to enhance contact center experiences using AI-powered solutions. This collaboration will allow Five9 clients to access SESTEK's advanced conversational tools, improving customer-agent interactions.

Portfolio Pulse from

November 13, 2024 | 2:00 pm

CL

Colgate-Palmolive (CL) is benefiting from strong pricing and productivity initiatives, along with a solid innovation strategy.

Portfolio Pulse from

November 13, 2024 | 2:00 pm

AAAU

Gold prices increased following U.S. inflation data that met expectations. This development may impact gold-related assets, such as the AAAU ETF, which tracks the price of gold.

Portfolio Pulse from

November 13, 2024 | 2:00 pm

FTQI

FTQI employs a buy-write strategy on the NASDAQ-100, offering a 12% yield through monthly distributions. It sells call options on all holdings, capping upside potential, making it suitable for income-focused investors. It has underperformed the NASDAQ 100, with a 76% ROI over 10 years compared to the index's 436%.

Portfolio Pulse from

November 13, 2024 | 2:00 pm

ARAAF

Aclara Resources Inc has partnered with the US Department of Commerce to find the best location for a rare earth separation facility in the US, aiming to bolster the supply chain for critical minerals.

Portfolio Pulse from

November 13, 2024 | 2:00 pm

VLTO

Veralto Corporation has invested $15 million in Axine Water Technologies, forming a strategic partnership to enhance water contaminant destruction technology.

Portfolio Pulse from

November 13, 2024 | 2:00 pm

VRT

Vertiv Holdings Co. (NYSE: VRT) has seen its stock rise over 160% year-to-date, driven by surpassing Q3 expectations and raising Q4 guidance. The company is gaining momentum in the AI-driven infrastructure market.

Portfolio Pulse from

November 13, 2024 | 1:45 pm

IRON

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company, will present at two upcoming investor conferences. This participation may provide insights into the company's progress and future plans.

Portfolio Pulse from

November 13, 2024 | 1:45 pm

ARTL

Artelo Biosciences has announced promising preclinical data for its lead clinical candidate, ART26.12, a non-opioid treatment for osteoarthritis pain. The data was presented at the 13th Annual Musculoskeletal Repair and Regeneration Symposium.

Portfolio Pulse from

November 13, 2024 | 1:45 pm

PAPL

Pineapple Financial Inc. has launched Renewals+, a platform that enhances customer retention and adds new revenue streams. The platform uses advanced data analytics and personalized engagement to achieve a 30% higher repeat business rate than industry standards, driving substantial revenue growth and shareholder value.

Portfolio Pulse from

November 13, 2024 | 1:45 pm